Low levels of CHD5 expression have been found in neuroblastoma cell lines, as well as correlating with MYCN amplification and poor prognosis in neuroblastoma tumors (Thompson et al., 2003; Fujita et al., 2008; Koyama et al., 2012). This evidence concerns the gene CHD5 and neuroblastoma.